Leading brokers name 3 ASX shares to sell today

Fortescue Metals Group Limited (ASX:FMG) shares are one of three that leading brokers have named as sells this week…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

On Monday I looked at three ASX shares that have been given buy ratings by leading brokers this week.

Unfortunately, not all shares are in favour with brokers right now. The three shares listed below have all just been given sell ratings. Here's why they are bearish on them:

Fortescue Metals Group Limited (ASX: FMG)

According to a note out of Morgans, its analysts have retained their reduce rating but lifted the price target on this iron ore producer's shares to $6.38 following its full year results. Whilst the result smashed Morgans expectations due to high iron ore prices, the broker is concerned by recent weakness in prices. In light of this and its current valuation, the broker has retained its reduce rating. The Fortescue share price is up 5.5% to $7.56 on Tuesday afternoon.

Goodman Group (ASX: GMG)

A note out of Goldman Sachs reveals that its analysts have retained their sell rating but lifted the price target on this property company's shares to $12.44 following the release of its full year results. According to the note, although Goodman Group delivered a 10.5% increase in earnings per share in FY 2019, Goldman felt the quality of its earnings growth was low in relation to the overall earnings mix. And while the broker thinks Goodman Group is a quality company, it isn't a fan of its current valuation and believes there are better options out there for investors to consider. The Goodman Group share price is down almost 3% to $14.88 today.

Mayne Pharma Group Ltd (ASX: MYX)

Analysts at the Macquarie equites desk have retained their underperform rating and 51 cents price target on this pharmaceutical company's shares. According to the note, the broker appears optimistic that its pipeline of drugs could give its earnings a boost over the medium term, but has concerns over the tough trading conditions it faces in the key generic drugs market at present. In light of this, it intends to stick with its underperform rating until it has seen improvements. Mayne Pharma's shares are down almost 5% to 45.7 cents today.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Unsure man analysing data on laptop.
52-Week Lows

Down 50% in the past year, are these ASX 200 shares too cheap to ignore?

These stocks have recently recovered from yearly lows.

Read more »

Man standing on the roof rack of a van next to boxes and gear
Share Market News

Global X says it's time to target this electric vehicle ASX ETF that has doubled in a year

Has EV investing finally moved from thematic to fundamental?

Read more »

Two excited woman pointing out a bargain opportunity on a laptop.
Broker Notes

4 reasons to buy Xero shares today

A leading expert forecasts sustained earnings growth for Xero shares. But why?

Read more »

A young boy wearing a hat, sunnies and striped singlet looks fierce and flexes his arm in victory.
Broker Notes

ASX 200 energy share with 'material long-term upside' ahead: fundie

Blackwattle highlights an ASX 200 energy producer with strong long-term growth potential.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Leading broker says this top ASX 200 share is a buy with 25%+ upside

Bell Potter thinks a buying opportunity has opened up for investors.

Read more »

Share Market News

Still down 40% over the past year, how high could WiseTech shares recover?

Is AI disruption going to boost or beat down this company?

Read more »

A happy male investor turns around on his chair to look at a friend while a laptop runs on his desk showing share price movements
Broker Notes

Morgans names 3 ASX 200 shares to buy now

Let's see why the broker is recommending these shares to clients.

Read more »

A team of people giving the thumbs up sign.
Share Gainers

This ASX 200 stock has jumped 149% in a year, and brokers tip more upside to come

The business has experienced huge demand across both of its two core business segments.

Read more »